We are live on ! Find out more
ETRM

EnteroMedics Inc.
ETRM

Delisted

ETRM was delisted on the 20th of October, 2017.

Back to rankings

26 hedge funds and large institutions have $1.14M invested in EnteroMedics Inc. in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

25,000% more call options, than puts

Call options by funds: $251K | Put options by funds: $1K

700% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 1

200% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 5

142% more capital invested

Capital invested by funds: $473K → $1.14M (+$671K)

44% more funds holding

Funds holding: 18 → 26 (+8)

Holders
26
Holders Change
+8
Holders Change %
+44.44%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
8
Reduced
1
Closed
5
Calls
$251K
Puts
$1K
Net Calls
+$250K
Net Calls Change
+$250K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$341K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$155K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$134K
4
EPM
Equitec Proprietary Markets
Illinois
+$95.2K
5
Citadel Advisors
Citadel Advisors
Florida
+$82.2K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$326K
2
SM
Sabby Management
Florida
-$67K
3
VKH
Virtu KCG Holdings
New York
-$3.76K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$267K +$341K +46,151 +33,202%
Vanguard Group
2
Vanguard Group
Pennsylvania
$230K +$155K +20,900 +109%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$182K +$134K +18,168 +135%
VKH
4
Virtu KCG Holdings
New York
$75K -$3.76K -508 -4%
EPM
5
Equitec Proprietary Markets
Illinois
$74K +$95.2K +12,870 New
Citadel Advisors
6
Citadel Advisors
Florida
$64K +$82.2K +11,119 New
TSS
7
Two Sigma Securities
New York
$59K +$76K +10,273 New
Bank of Montreal
8
Bank of Montreal
Ontario, Canada
$55K +$71K +9,600 New
UBS Group
9
UBS Group
Switzerland
$53K +$60K +8,110 +735%
FPF
10
FNY Partners Fund
New York
$40K +$51.8K +7,000 New
NIT
11
NumerixS Investment Technologies
British Columbia, Canada
$9K +$11.1K +1,500 New
Parallax Volatility Advisers
12
Parallax Volatility Advisers
California
$8K +$9.72K +1,314 +6,916%
Creative Planning
13
Creative Planning
Kansas
$6K +$6.94K +939 +1,323%
Deutsche Bank
14
Deutsche Bank
Germany
$5K +$7.46K +1,009 New
CG
15
Cutler Group
California
$3K – – –
FANJ
16
Financial Architects (New Jersey)
New Jersey
$3K +$3.7K +500 New
WAM
17
Wealthspire Advisors (Maryland)
Maryland
$3K +$3.7K +500 New
Manulife (Manufacturers Life Insurance)
18
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2K – – –
SPIA
19
Steward Partners Investment Advisory
New York
$2K +$2.96K +400 New
Barclays
20
Barclays
United Kingdom
$2K +$2.96K +401 New
BlackRock
21
BlackRock
New York
$1K +$1.06K +144 New
Group One Trading
22
Group One Trading
Illinois
$1K +$1.25K +169 +994%
Renaissance Technologies
23
Renaissance Technologies
New York
– -$326K -162,765 Closed
SM
24
Sabby Management
Florida
– -$67K -33,387 Closed
EWM
25
Evercore Wealth Management
New York
– +$7 +1 New
1
2

ETRM Hedge Fund Activity: Q1 2017 in Review

26 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in EnteroMedics Inc. (ETRM) for Q1 2017, worth a combined $1.14M — up 142% from $473K a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new ETRM positions and 5 closed out — a net gain of 10 holders — while 8 added to existing stakes and 1 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $341K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $326K sold.

  • 26 institutional investors held EnteroMedics Inc. (ETRM) as of Q1 2017, up from 18 in Q4 2016.
  • Funds reported $1.14M of EnteroMedics Inc. stock for Q1 2017, up 142% quarter-over-quarter.
  • 15 funds opened new EnteroMedics Inc. positions in Q1 2017 and 5 closed out, a net change of +10 holders.
  • The largest EnteroMedics Inc. buyer in Q1 2017 was Morgan Stanley, an estimated $341K added.
  • The largest EnteroMedics Inc. seller in Q1 2017 was Renaissance Technologies, an estimated $326K sold.

Based on aggregated 13F filings for Q1 2017.